Home > Healthcare > Active Pharmaceutical Ingredients Market > Table of Contents

Active Pharmaceutical Ingredients Market - By Therapeutic Category (Oncology, Infectious Diseases, Anti-Diabetics, CNS & Anesthesia), By Synthesis (Chemical Based API, Biological API, HPAPI), By Contract Outsourcing, By Application, By Drug & Forecast, 2023-2032

  • Report ID: GMI5415
  • Published Date: Jan 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Methodology

1.2    Market scope & definitions

1.3    Base estimates & working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Active Pharmaceutical Ingredients industry 3600 synopsis, 2018-2032

2.1.1    Business trends

2.1.2    Therapeutic category trends

2.1.3    Synthesis type trends

2.1.4    Contract outsourcing type trends

2.1.5    Application trends

2.1.6    Drug type trends

2.1.7    Regional trends

Chapter 3   Active Pharmaceutical Ingredients Industry Insights

3.1    Industry landscape, 2018-2032 (USD Million)

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Growing prevalence of chronic diseases

3.2.1.2    Rising drug research and development activities

3.2.1.3    Increasing demand for generics

3.2.1.4    Increasing uptake of biopharmaceuticals

3.2.2    Industry pitfalls & challenges

3.2.2.1   Unfavourable drug price control policies

3.2.2.2   High manufacturing costs

3.3    Growth potential analysis

3.3.1    By therapeutic category trends

3.3.2    By synthesis type trends

3.3.3    By contract outsourcing type trends

3.3.4    By application trends

3.3.5    By drug type trends

3.4    COVID-19 impact analysis

3.5    Technology landscape

3.6    Supply chain analysis

3.7    key market trends

3.8    Pipeline analysis

3.9    Regulatory landscape

3.9.1    U.S.

3.9.2    Europe

3.9.3    Asia Pacific

3.10    Vendor matrix analysis

3.11    API manufacturing trends

3.12    Overview of API Production

3.12.1    Share of supply in (%) Total European Demand in Tons

3.12.2    Overview of CEPS, APIs and Manufacturers By Region (2000-2020)

3.12.3    Overview of development of the number of valid CEPS (2000 -2020)

3.12.4    Overview of global distribution of currently valid CEPS (2020)

3.12.5    Analyst insights

3.13    Policy landscape

3.13.1    China

3.13.2    India

3.14    Porter's analysis

3.15    PESTEL analysis

Chapter 4   Competitive Landscape, 2021

4.1    Introduction

4.2    Company matrix analysis, 2021

4.3    Strategy dashboard, 2021

4.4    Strategy landscape

Chapter 5   Active Pharmaceutical Ingredients Market, By Therapeutic Category

5.1    Key therapeutic category trends

5.2    Oncology

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3    Infectious diseases

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.4    Anti-diabetics

5.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.5    CNS & anesthesia

5.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.6    Cardiovascular diseases

5.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.7    Biologics

5.7.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.8    Others

5.8.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6   Active Pharmaceutical Ingredients Market, By Synthesis Type

6.1    Key synthesis type trends

6.2    Chemical based API

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Biological API

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Highly potent API (HPAPI)

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   Active Pharmaceutical Ingredients Market, By Contract Outsourcing Type

7.1    Key contract outsourcing type trends

7.2    CDMO

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    CMO

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   Active Pharmaceutical Ingredients Market, By Application

8.1    Key application trends

8.2    Humans

8.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.3    Veterinary

8.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9   Active Pharmaceutical Ingredients Market, By Drug Type

9.1    Key drug type trends

9.2    Prescription

9.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

9.3    OTC

9.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 10   Active Pharmaceutical Ingredients Market, By Region

10.1    Key regional trends

10.2    North America

10.2.1    U.S.

10.2.2    Canada

10.3    Europe

10.3.1    Switzerland

10.3.2    France

10.3.3    Italy

10.3.4    Germany

10.3.5    UK

10.3.6    Spain

10.4    Asia Pacific

10.4.1    China

10.4.2    Japan

10.4.3    India

10.4.4    Australia

10.4.5    South Korea

10.4.6    Vietnam

10.4.7    Indonesia

10.4.8    Thailand

10.5    Latin America

10.5.1    Brazil

10.5.2    Mexico

10.5.3    Argentina

10.5.4    Colombia

10.5.5    Chile

10.5.6    Peru

10.6    MEA

10.6.1    South Africa

10.6.2    Saudi Arabia

10.6.3    UAE

10.6.4    Qatar

10.6.5    Bahrain

10.6.6    Egypt

Chapter 11   Company Profiles

11.1    Merck & Co., Inc.

11.2    Aarti Drugs Ltd

11.3    Biocon Ltd.

11.4    Qilu Pharmaceutical Co., Ltd.

11.5    Divi's Laboratories Limited

11.6    EUROAPI

11.7    Hikal Ltd.

11.8    Teva Pharmaceutical Industries Ltd

11.9    Cipla Ltd.

11.10    Neuland Laboratories Ltd.

11.11    Aurobindo Pharma Ltd

11.12    Sun Pharmaceutical Industries Ltd.

11.13    Dr. Reddy’s Laboratories Ltd

11.14    Pfizer, Inc

11.15    Solara Active Pharma

11.16    Alivira Animal Health Ltd

11.17    SUANFARMA

11.18    Procyon Life Sciences

11.19    NGL Fine-Chem Ltd

11.20    Ofichem Group
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 20
  • Tables & Figures: 423
  • Countries covered: 28
  • Pages: 295
 Download PDF